Self-efficacy and Knowledge (SEEK) Trial to Improve Sexual Reproductive Health and Well-being for Syrian Refugee Women and Girls in Lebanon
SEEK
2 other identifiers
interventional
485
1 country
1
Brief Summary
This community-based randomized controlled trial (RCT) aims to evaluate a low-resource/low-intensity integrated sexual reproductive health (SRH) and wellbeing intervention package. It will be delivered in Primary Healthcare Centres (PHCs) in a rural area in Lebanon to Syrian refugee women and girls aged 15-24.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJune 6, 2025
June 1, 2025
1.3 years
February 28, 2025
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Family Planning Use
Improvement in family planning use among the EG compared to the CG at 3 months post intervention. This will be measured using the Pan Arab-Family Health (PAPFAM) survey. This is a descriptive tool with values indicating use or no use of family planning services. It is not scored, but rather yields un-scored percentages. Higher percentages may mean worse or better outcomes depending on the question.
From enrollement until 3 months post intervention delivery
Secondary Outcomes (4)
Anxiety and Depression Measure
From enrollment until 3 months post intervention
General Wellbeing Measure
From enrollment until the end of 3 months post treatment follow up
Self Efficacy Measure
From enrollment until the end of the intervention at 3 months post treatment
Perceived Social Support Measure
From enrollment until the end of the intervention at 3 months post treatment
Other Outcomes (3)
Emotional Regulation Measure
From enrollement until 3 months post intervention delivery
Interpersonal Communication Measure
From enrollment until 3 months post intervention
Ways of Coping Measure
From enrollment until 3 months post intervention
Study Arms (2)
Group receiving SEEK intervention
EXPERIMENTALParticipants randomly assigned to the experimental group will be further randomly assigned to 16 subgroups of no more than 12 participants per groups to receive the SEEK integrated intervention package on sexual reproductive health, family planning, and wellbeing.
Control group not receiving SEEK intervention
NO INTERVENTIONInterventions
The intervention is composed on 8 sessions given over a period of 8 weeks covering topics of emotional regulation, communication, problem management, decision making, self-efficacy and others in relation to sexual reproductive health, family planning, and wellbeing. The intervention package will be delivered by trained non-specialists with at least 12 years of formal education. The package will be administered once a week for a duration of 90 minutes.
Eligibility Criteria
You may qualify if:
- are currently married and between the ages of 15 - 24 years,
- completed an average stay in Lebanon for a minimum of 6 months,
- are willing to take part in the study as indicated by them signing an informed consent (for young women 18 years of age or older) or through a legal guardian consent form and written assent for adolescents' girls between 15 and 17,
You may not qualify if:
- Participants will be excluded from the study if they meet any of the following criteria:
- are currently pregnant and/or lactating,
- have reported chronic health problems interfering with the ability to follow the intervention protocol,
- have high levels of anxiety and/or depression as well as suicidal ideations and/or attempts upon screening and/or a current diagnosis of a severe mental illness, or undergoing mental health treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- American University of Beirut Medical Centerlead
- World Health Organizationcollaborator
- Elrhacollaborator
Study Sites (1)
American University of Beirut
Beirut, 00000, Lebanon
Related Publications (1)
Sarieddine D, Chamseddine Z, Naal H, Dakdouki AE, Haidar GHA, Tamim H, Bosqui T, Fouad F, Ibrahim S, Sater ZA, Saleh S. Correlates of sexually transmitted infections among Syrian refugee women and girls in Lebanon: knowledge, symptoms, and health-seeking behaviors. BMC Womens Health. 2025 Oct 8;25(1):477. doi: 10.1186/s12905-025-04036-z.
PMID: 41063145DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Shadi Saleh, PhD
Global Health Institute American University of Beirut
- PRINCIPAL INVESTIGATOR
Lale Say, MD
World Health Organization
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Founding Director of the Global Health Institute
Study Record Dates
First Submitted
February 28, 2025
First Posted
June 6, 2025
Study Start
January 1, 2024
Primary Completion
May 1, 2025
Study Completion
June 30, 2025
Last Updated
June 6, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Given the sensitive nature of the topic of this research, IPD will not be shared with other researchers. The studied population represents vulnerable individuals from refugee groups, and so ensuring confidentiality is necessary to keep in line with ethical guidelines and institutional policies, especially that IPD sharing was not communicated to AUB's IRB or to participants enrolled in the trial. Upon publication however, data can be made available as de-identified data to other researchers upon reasonable requests.